Charles Schwab’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.3M | Buy |
652,669
+8,498
| +1% | +$306K | ﹤0.01% | 1565 |
|
|
2026
Q1 | $15.8M | Buy |
644,171
+95,019
| +17% | +$2.25M | ﹤0.01% | 1871 |
|
|
2025
Q4 | $13.6M | Sell |
549,152
-13,162
| -2% | -$350K | ﹤0.01% | 1973 |
|
|
2025
Q3 | $15.9M | Buy |
562,314
+60,734
| +12% | +$1.65M | ﹤0.01% | 1870 |
|
|
2025
Q2 | $12.5M | Buy |
501,580
+2,051
| +0.4% | +$57.8K | ﹤0.01% | 1902 |
|
|
2025
Q1 | $15.5M | Buy |
499,529
+28,200
| +6% | +$939K | ﹤0.01% | 1752 |
|
|
2024
Q4 | $14.9M | Buy |
471,329
+23,533
| +5% | +$1.12M | ﹤0.01% | 1842 |
|
|
2024
Q3 | $25.9M | Buy |
447,796
+25,307
| +6% | +$1.24M | 0.01% | 1547 |
|
|
2024
Q2 | $17.1M | Buy |
422,489
+36,719
| +10% | +$1.46M | ﹤0.01% | 1772 |
|
|
2024
Q1 | $16.2M | Buy |
385,770
+41,741
| +12% | +$1.63M | ﹤0.01% | 1729 |
|
|
2023
Q4 | $13.2M | Buy |
344,029
+13,526
| +4% | +$450K | ﹤0.01% | 1849 |
|
|
2023
Q3 | $10.2M | Buy |
330,503
+19,060
| +6% | +$658K | ﹤0.01% | 1896 |
|
|
2023
Q2 | $9.84M | Buy |
311,443
+13,179
| +4% | +$452K | ﹤0.01% | 1915 |
|
|
2023
Q1 | $10.9M | Sell |
298,264
-2,694
| -0.9% | -$94.3K | ﹤0.01% | 1831 |
|
|
2022
Q4 | $8.91M | Buy |
300,958
+8,455
| +3% | +$272K | ﹤0.01% | 1925 |
|
|
2022
Q3 | $11.4M | Buy |
292,503
+21,389
| +8% | +$979K | ﹤0.01% | 1763 |
|
|
2022
Q2 | $10.5M | Sell |
271,114
-2,975
| -1% | -$113K | ﹤0.01% | 1818 |
|
|
2022
Q1 | $13.3M | Buy |
274,089
+7,205
| +3% | +$372K | ﹤0.01% | 1793 |
|
|
2021
Q4 | $19.6M | Buy |
266,884
+4,989
| +2% | +$410K | 0.01% | 1598 |
|
|
2021
Q3 | $23.8M | Buy |
261,895
+121,757
| +87% | +$10.4M | 0.01% | 1429 |
|
|
2021
Q2 | $8.8M | Buy |
140,138
+36,407
| +35% | +$1.35M | ﹤0.01% | 2065 |
|
|
2021
Q1 | $2.81M | Sell |
103,731
-1,226
| -1% | -$29.5K | ﹤0.01% | 2550 |
|
|
2020
Q4 | $1.92M | Buy |
104,957
+2,649
| +3% | +$47.6K | ﹤0.01% | 2598 |
|
|
2020
Q3 | $1.84M | Sell |
102,308
-34,749
| -25% | -$599K | ﹤0.01% | 2516 |
|
|
2020
Q2 | $2.26M | Buy |
137,057
+20,982
| +18% | +$330K | ﹤0.01% | 2380 |
|
|
2020
Q1 | $1.5M | Buy |
116,075
+6,916
| +6% | +$113K | ﹤0.01% | 2381 |
|
|
2019
Q4 | $2.01M | Sell |
109,159
-44,688
| -29% | -$741K | ﹤0.01% | 2415 |
|
|
2019
Q3 | $2.71M | Buy |
153,847
+134,025
| +676% | +$2.29M | ﹤0.01% | 2279 |
|
|
2019
Q2 | $332K | Buy |
19,822
+6,816
| +52% | +$124K | ﹤0.01% | 2978 |
|
|
2019
Q1 | $239K | Hold |
13,006
| – | – | ﹤0.01% | 2988 |
|
|
2018
Q4 | $259K | Hold |
13,006
| – | – | ﹤0.01% | 2976 |
|
|
2018
Q3 | $288K | Sell |
13,006
-33,194
| -72% | -$699K | ﹤0.01% | 3015 |
|
|
2018
Q2 | $1.2M | Buy |
+46,200
| New | +$792K | ﹤0.01% | 2534 |
|
Other funds holding ASTH
3C
Charles Schwab's ASTH Position: Q2 2026 in Review
Charles Schwab increased its Astrana Health (ASTH) stake by 1.3% in Q2 2026, buying an estimated $306K and bringing the position to 652,669 shares worth $30.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1565.
Charles Schwab first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Charles Schwab held 652,669 shares of Astrana Health worth $30.3M as of Q2 2026.
- Charles Schwab bought 8,498 Astrana Health shares in Q2 2026, an estimated $306K.
- Astrana Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1565 holding.
- Charles Schwab first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.